1. Home
  2. BHF vs CDNA Comparison

BHF vs CDNA Comparison

Compare BHF & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brighthouse Financial Inc.

BHF

Brighthouse Financial Inc.

HOLD

Current Price

$41.16

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$77.08

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHF
CDNA
Founded
2016
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.3B
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
BHF
CDNA
Price
$41.16
$77.08
Analyst Decision
Hold
Buy
Analyst Count
7
7
Target Price
$60.83
★ $93.50
AVG Volume (30 Days)
720.3K
★ 1.4M
Earning Date
11-17-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.06
N/A
EPS
★ 2.84
2.45
Revenue
★ $6,766,000,000.00
$48,324,000.00
Revenue This Year
$24.39
$38.20
Revenue Next Year
$1.79
$9.07
P/E Ratio
★ $14.95
$35.04
Revenue Growth
★ 43.23
18.93
52 Week Low
$41.98
$14.72
52 Week High
$66.80
$90.87

Technical Indicators

Market Signals
Indicator
BHF
CDNA
Relative Strength Index (RSI) 22.31 73.25
Support Level N/A $17.30
Resistance Level $63.55 N/A
Average True Range (ATR) 1.32 4.79
MACD -0.23 1.62
Stochastic Oscillator 6.54 82.12

Price Performance

Historical Comparison
BHF
CDNA

About BHF Brighthouse Financial Inc.

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are: Annuities, that derives majority of the revenue, includes variable, fixed, index-linked, and income annuities; The life segment includes variable, term, universal, and whole life policies; The Run-off segment consists of products that are no longer actively sold and are separately managed, including ULSG, structured settlements, pension risk transfer contracts, certain company-owned life insurance policies and certain funding agreements; and The Corporate & Other segment consists of activities related to funding agreements associated with the company.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: